Stock listing

A2H5A0 Stock Price, News, Filings & Events — Rhythm Pharmaceuticals, Inc.

Selected listing: A2H5A0 · LS · EUR · DE

This page tracks Rhythm Pharmaceuticals, Inc.'s A2H5A0:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2H5A0:LS. A2H5A0:LS is the stock-level entry point for investors researching Rhythm Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Rhythm Pharmaceuticals, Inc. (Ticker: RYTM) is a public company based in the United States, specializing in the development of innovative therapies for rare genetic diseases related to obesity. With a market capitalization of approximately $7 billion, Rhythm focuses on addressing unmet medical needs through its research and development efforts. The company's commitment to improving patient outcomes positions it as a key...

A2H5A0:LSEURDEUpdated August 14, 2026
Rhythm Pharmaceuticals, Inc. logo
Ticker
A2H5A0:LS
Asset type
Stock
Market cap
$7.95B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
LS
Currency
EUR

Rhythm Pharmaceuticals, Inc. A2H5A0:LS stock context

This page tracks Rhythm Pharmaceuticals, Inc.'s A2H5A0:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2H5A0:LS. A2H5A0:LS is the stock-level entry point for investors researching Rhythm Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Rhythm Pharmaceuticals, Inc. (Ticker: RYTM) is a public company based in the United States, specializing in the development of innovative therapies for rare genetic diseases related to obesity. With a market capitalization of approximately $7 billion, Rhythm focuses on addressing unmet medical needs through its research and development efforts. The company's commitment to improving patient outcomes positions it as a key...

Research Rhythm Pharmaceuticals, Inc.

Alternate listings